DexCom
DXCM
#877
Rank
A$40.22 B
Marketcap
A$103.13
Share price
1.12%
Change (1 day)
-27.61%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2024: A$1.02 Billion

According to DexCom's latest financial reports the company's current earnings are A$4.51 Billion. In 2024 the company made an earning of A$1.02 Billion a decrease over its 2023 earnings that were of A$1.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2024

Annual earnings

Year Earnings Change
2024A$1.02 B-0.37%
2023A$1.03 B78.13%
2022A$0.57 B47.34%
2021A$0.39 B-10.11%
2020A$0.43 B88.27%
2019A$0.23 B-258.48%
2018-A$0.15 Billion189.94%
2017-A$50.53 Million-44.24%
2016-A$90.6 Million12.43%
2015-A$80.58 Million165.58%
2014-A$30.35 Million-25.61%
2013-A$40.79 Million-48.11%
2012-A$78.6 Million24.5%
2011-A$63.14 Million
2008-A$74.55 Million13.18%
2007-A$65.87 Million-5.36%
2006-A$69.61 Million52.08%
2005-A$45.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.71 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.48 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.04 B 555.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
A$2.65 B 92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$2.40 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.29 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-A$1.61 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
A$0.85 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA